Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Hepion Pharmaceuticals Inc’s stock clocked out at $0.42, down -2.11% from its previous closing price of $0.43. In other words, the price has decreased by -$2.11 from its previous closing price. On the day, 23.63 million shares were traded. HEPA stock price reached its highest trading level at $0.615 during the session, while it also had its lowest trading level at $0.405.
Ratios:
To gain a deeper understanding of HEPA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.51 and its Current Ratio is at 0.51.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HEPA now has a Market Capitalization of 455760 and an Enterprise Value of 8820286.
Stock Price History:
The Beta on a monthly basis for HEPA is 1.75, which has changed by -0.99612844 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, HEPA has reached a high of $117.70, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -90.41%, while the 200-Day Moving Average is calculated to be -98.40%.
Shares Statistics:
It appears that HEPA traded 3.64M shares on average per day over the past three months and 18269440 shares per day over the past ten days. A total of 10.98M shares are outstanding, with a floating share count of 10.92M. Insiders hold about 29.36% of the company’s shares, while institutions hold 0.28% stake in the company. Shares short for HEPA as of 1743379200 were 199814 with a Short Ratio of 0.05, compared to 1740700800 on 83200. Therefore, it implies a Short% of Shares Outstanding of 199814 and a Short% of Float of 18.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
